Filing Details
- Accession Number:
- 0001213900-21-055664
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-01 09:15:25
- Reporting Period:
- 2021-10-28
- Accepted Time:
- 2021-11-01 09:15:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1522602 | Cohbar Inc. | CWBR | Pharmaceutical Preparations (2834) | 261299952 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1791221 | Misha Petkevich | C/O Cohbar, Inc. 1455 Adams Drive, Suite 2050 Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-10-28 | 167,000 | $0.58 | 407,609 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnote |
Footnotes
- The Reporting Person is a General Partner of V2M Life Sciences L.P. ("V2M"), and has sole voting and dispositive power over the securities held by V2M. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.